Penumbra, Inc Restructuring Reserve, Settled without Cash
Penumbra, Inc (PEN) reported Restructuring Reserve, Settled without Cash of $4.97 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-18.
Financial Statements › Notes
us-gaap:RestructuringReserveSettledWithoutCash2 · last filed 2025-02-18
- Penumbra, Inc restructuring reserve, settled without cash for the quarter ending 2024-12-31 was $3.53M.
- Penumbra, Inc restructuring reserve, settled without cash for fiscal 2024 was $4.97M.
| Period end | Restructuring Reserve, Settled without Cash 3 month | Restructuring Reserve, Settled without Cash 9 month | Restructuring Reserve, Settled without Cash 12 month |
|---|---|---|---|
| 2024-12-31 | $3.53M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $4.97M 10-K · filed 2025-02-18 | |
| 2024-09-30 | $1.44M 10-Q · filed 2024-10-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |